ADAM2 and neoplasm: In addition, although ACT treatment significantly reduced the tumor burden in control lungs, it did not have a significant therapeutic effect in sgAdam2-deficient lungs—in fact there was a trend towards increased growth of treated Adam2-deficient tumors (Fig. 3E and Supplementary Fig. 11c–g).